Massimo Morra

Personalis (United States) — United States

Immunology and Microbiology · Life Sciences

19h-index2.1kcitations39works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(11), Genomics and Rare Diseases(11), Immunodeficiency and Autoimmune Disorders(10), Cancer Genomics and Diagnostics(7), T-cell and B-cell Immunology(6)

Publications39 total

Analytic validation of NeXT Dx™, a comprehensive genomic profiling assay
Oncotarget·2023· 4 citedOpen Access
Abstract 1334: A diagnostic platform for precision cancer therapy enabling composite biomarkers by combining tumor and immune features from an enhanced exome and transcriptome
Cancer Research·2020· 1 cited
Validation of an exome and transcriptome based diagnostic platform enabling clinical cancer therapy selection and emerging composite biomarkers for immunotherapy.
Journal of Clinical Oncology·2020
A survey of current practices for genomic sequencing test interpretation and reporting processes in US laboratories
UNC Libraries·2020Open Access
Abstract A051: A comprehensive, highly accurate genomics platform for precision immunotherapy: Simultaneously characterize tumors and the TME from a single FFPE sample
Molecular Cancer Therapeutics·2019
Probable Diagnosis of a Patient with Niemann–Pick Disease Type C: Managing Pitfalls of Exome Sequencing
JIMD Reports·2018· 1 citedOpen Access
A variant by any name: quantifying annotation discordance across tools and clinical databases
Genome Medicine·2017· 76 citedOpen Access
A survey of current practices for genomic sequencing test interpretation and reporting processes in US laboratories
Genetics in Medicine·2016· 84 citedOpen Access
Abstract 4744: Solving genomic assay trade-offs with an optimized, extended cancer gene panel for research and clinical applications
Cancer Research·2015
Achieving high-sensitivity for clinical applications using augmented exome sequencing
Genome Medicine·2015· 56 citedOpen Access
Additional file 8: of Achieving high-sensitivity for clinical applications using augmented exome sequencing
Figshare·2015Open Access
Additional file 9: of Achieving high-sensitivity for clinical applications using augmented exome sequencing
Figshare·2015Open Access
Additional file 3: of Achieving high-sensitivity for clinical applications using augmented exome sequencing
Figshare·2015Open Access
Additional file 10: of Achieving high-sensitivity for clinical applications using augmented exome sequencing
Figshare·2015Open Access
Additional file 2: of Achieving high-sensitivity for clinical applications using augmented exome sequencing
Figshare·2015Open Access
Additional file 11: of Achieving high-sensitivity for clinical applications using augmented exome sequencing
Figshare·2015Open Access
2012 ESRF FACULTY JUDGES The directors and staff of the 2012 ESRF would like to express their gratitude to the following individuals for contributing their time and expertise in the evaluation of this year's Forum presentations:
2012
Idiopathic CD4+ Lymphopenia Associated with a Heterozygous RAG1 Mutation in an Adult
Clinical Immunology·2010
IgA and IgG Hypogammaglobulinemia Does Not Predict for Recurrent Infection Risk and Persists Despite Therapeutic Response in Patients with Waldentrom's Macroglobulinemia.
Blood·2009
Novel presentation of Omenn syndrome in association with aniridia
Journal of Allergy and Clinical Immunology·2009· 15 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Jason Harris(13), Richard Chen(12), John West(11), Gábor Bartha(11), Cox Terhorst(10), Christian Haudenschild(10), Michael J. Clark(10), Stephen A. Chervitz(9), Deanna M. Church(9), Sarah Garcia(8), Anil Patwardhan(8), Shujun Luo(8), Nan Leng(7), Mark Pratt(7), Justin M. Zook(7), Marc Salit(7), Jeanie Tirch(7), Gemma Chandratillake(7), Scott Kirk(7), Euan A. Ashley(7)